NSEAnalysts/Institutional Investor Meet/Con. Call Updates3d ago · 11 Aug 2026, 03:21 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Hindustan Foods Limited · HNDFDS
✦ AI Summary▲ PositiveResults
Hindustan Foods Limited has reported a strong Q1 FY '27 performance, with a 33% growth in PAT, driven by robust demand and operational efficiencies. The company has signed new projects worth INR340 crores and expects to commercialize manufacturing capacities exceeding INR500 crores during FY '27.
Analysis Scores
Earnings Impact8/10
Growth Catalyst7/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment9/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Hindustan Foods Limited has informed the Exchange about Transcript
Attachments (1)
📄pdf
Download →
9136565850_11082026151857_Transcript.pdf
View document text
HINDUSTAN FOODS LIMITED
A Vanity Case Group Company
A Government Recognised Two Star Export House
Registered Office: Office No. 3, Level 2, Centrium, Phoenix Market City,
15, Lal Bahadur Shastri Road, Kurla (West), Mumbai, Maharashtra, India, 400 070.
Email: business@thevanitycase.com, Website: www.hindustanfoodslimited.com
Tel. No.: +91 22 6980 1700/01, CIN: L15139MH1984PLC316003
Date: August 11, 2026
To, To,
The General Manager The Manager,
Department of Corporate Services N a t i o n a l S tock Exchange of India Limited,
BSE Limited Listing Department,
Floor 25, P. J. Towers, Dalal Street, Exchange Plaza, C-1, Block G,
Mumbai‐ 400 001 Bandra Kurla Complex,
Tel: (022) 2272 1233 / 34 Bandra (East), Mumbai 400 070
Company Scrip Code: 519126 Company Symbol: HNDFDS
Dear Sir/Madam,
Sub: Transcript of Analyst/Investors conference call held on August 5, 2026
Ref: Pursuant to Regulation 30(2) of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015
With reference to our letter dated July 29, 2026 intimating you about the conference call with
Analyst/Investors which was held on August 5, 2026, please find attached the transcript of
the aforesaid conference call.
The above information will also be available on the website of the Company i.e.
www.hindustanfoodslimited.com.
We request you to kindly take the above information on record.
Thanking you,
Yours faithfully,
For HINDUSTAN FOODS LIMITED
Bankim Purohit
Company Secretary and Legal Head
ACS 21865
Encl: as above
“Hindustan Foods Limited
Q1 FY ‘27 Earnings Conference Call”
August 05, 2026
This transcript is edited for factual errors. In case of discrepancy, the audio recordings uploaded on the website of the
Company on 05th August 2026 will prevail
MANAGEMENT: MR. SAMEER KOTHARI – MANAGING DIRECTOR –
HINDUSTAN FOODS LIMITED
MR. MAYANK SAMDANI – GROUP CHIEF FINANCIAL
OFFICER – HINDUSTAN FOODS LIMITED
MR. GANESH ARGEKAR – EXECUTIVE DIRECTOR –
HINDUSTAN FOODS LIMITED
MR. VIMAL SOLANKI - HEAD OF CORPORATE
COMMUNICATIONS
SGA – INVESTOR RELATIONS ADVISOR – HINDUSTAN
FOODS LIMITED
Moderator: Ladies and gentlemen, good day, and welcome to the Hindustan Foods Limited Q1 FY '27
Earnings Conference Call. As a reminder, all participant lines will be in the listen only mode and
there will be an opportunity for you to ask questions at the end of today's presentation. Should
you need assistance during the conference call, please signal an operator by pressing star then
zero on your touchtone phone. Please note that this conference is being recorded.
I would now like to hand the conference over to Mr. Sameer Kothari, Managing Director from
Hindustan Foods Limited. Thank you, and over to you, sir.
Sameer Kothari: Thank you. Good morning, and welcome to our Q1 FY '27 Earnings Conference Call. Joining
me on today's call are Ganesh Argekar, Executive Director; Mayank Samdani, Group CFO;
Vimal Solanki, Head, Corporate Communications; and SGA, our Investor Relations Advisor. I
trust all of you have had an opportunity to review our earnings presentation, which has been
uploaded on the stock exchanges and our company website. We are quite pleased with the
performance of the company in this quarter.
In spite of the headwinds in terms of the macro environment, especially around the elevated
inflationary pressures and the geopolitical risks, the quarter's performance is a vindication that
the long-term opportunity for FMCG contract manufacturing in India remains compelling.
Increased outsourcing by consumer brands, rising consumption, premiumization and the
growing preference for asset-light manufacturing continues to expand the addressable market
for HFL.
Coming to the financial performance, we have started FY '27 on a strong note. While our
footwear business faced temporary cost pressures during the quarter due to higher raw material
prices arising from the Middle East crisis and the implementation of the revised wage rates, the
underlying performance across our other businesses remained robust.
Leveraging the strength of our diversified manufacturing platform, we delivered our highest ever
quarterly PAT with a growth of nearly 1/3, 33% over last year. Reflecting the continued
confidence of our customers and the robust demand outlook across our businesses, we have
already signed on various projects totaling to around INR340 crores in this financial year.
Including these investments and the projects already under implementation, we expect to
commercialize manufacturing capacities exceeding INR500 crores during FY '27. Additionally,
we continue to engage with our customers for various new projects, which gives us the
confidence not only to reaffirm our FY '27 PAT guidance of INR200 crores to INR220 crores,
but also makes us optimistic about sustaining this growth in FY '28 and beyond.
With that, I would like to hand over the call to Ganesh, who will take you through the operational
highlights of the quarter.
Ganesh Argekar: Thank you, Sameer. I will now take you through the operational highlights for the first quarter
of FY '27. We have started the year on a strong operational footing with healthy execution across
our manufacturing networks and encouraging progress across all our business segments. The
capacities commissioned over the past few quarters continue to ramp up well, while our team
remains focused on improving operational efficiencies, onboarding new customers and
strengthening existing customer relationships.
Our Home and Personal Care business remains at maximum capacity, supported by consistent
demand and efficient manufacturing operations. We are seeing some traction in demand for these
products across all categories and across all sites. Based on this, the division delivered a record
performance this quarter.
The integration of the Aurangabad Personal Care facility has now been successfully completed
with production stabilized and the plant operating seamlessly within our manufacturing network.
The brownfield expansion at Silvassa is expected to commence production during the second
quarter, while the greenfield Lucknow facility continues to progress as planned for
commissioning later this year.
Our Food and Beverages business continued to witness healthy momentum across multiple
categories. The Coimbatore, Nashik and Mysore units continue to operate at record production
levels, supported by efficient operations and sustained demand. The Beverage division had an
excellent season and validates our belief that beverages will be one of the major avenues of
growth for this division. We are also expanding our manufacturing platform with addition of a
Greek yogurt facility in Goa, marking our entry into another high-growth category.
The ice cream business delivered another strong quarter, supported by robust summer season
and record production volumes across our manufacturing facilities. During the quarter, we
successfully commissioned our state-of-the-art Panipat facility and continue to expand our ice
cream manufacturing capacities. This capacity expansion will enable us to cater to growing
customer demand and support the long-term growth of the category. We also continue to improve
asset utilization at our Nashik operations by adding new customers across both the ice cream
and cone manufacturing facilities.
Within health care, we continue to strengthen our capabilities by adding new customers across
syrup, tablets and lozenges while progressing our ayurvedic wellness expansion at Baddi. We
also initiated the certification process for Class III medical devices at our Chennai facility, which
will support our expansion into regulated international markets over time. We are actively
pursuing new export opportunities for our personal care product portfolio manufactured at Baddi
facility. With scalable production capabilities and a strong focus on quality, we are engaging
with international customers and partners to expand our presence in global markets.
Our footwear business continued to make steady pr
[Showing first 8,000 characters — download PDF for full document]